BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.



Operations

Quality Assurance

Ness Ziona, Israel

BiomX

bio-it

A Silicon Valley venture capital firm dedicated to creating value through technology.

Join us